Payment overview · 2025
General Payments
$27,031.52
61 reported records · 24 companies
Healthcare provider profile · identity verified
Govindarajan Narayanan, MD
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · MIAMI, FL · NPI 1699794297
Verified facts
What the public records show
CMS Open Payments records show Govindarajan Narayanan, MD received $27,031.52 in general payments during 2025 across 61 reported records.
AngioDynamics, Inc. accounted for 42.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 36 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $11,539.15 | 42.7% | 10 | 2025 |
| Single Pass Inc | Unresolved — no canonical attribution shown | $5,750.00 | 21.3% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $4,800.66 | 17.8% | 10 | 2025 |
| HISTOSONICS, INC. | Unresolved — no canonical attribution shown | $2,984.97 | 11.0% | 2 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $281.27 | 1.0% | 5 | 2025 |
| Delcath Systems | Unresolved — no canonical attribution shown | $213.74 | 0.8% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$210.90 | 0.8% | 5 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $197.27 | 0.7% | 4 | 2025 |
| Siemens Medical Solutions USA, Inc. | Unresolved — no canonical attribution shown | $162.18 | 0.6% | 2 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $150.84 | 0.6% | 3 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $133.62 | 0.5% | 1 | 2025 |
| ABK Biomedical USA, Inc. | Unresolved — no canonical attribution shown | $123.47 | 0.5% | 2 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $70.67 | 0.3% | 2 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $62.67 | 0.2% | 2 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $50.85 | 0.2% | 2 | 2025 |
| Mozarc Medical US LLC | Unresolved — no canonical attribution shown | $46.34 | 0.2% | 1 | 2025 |
| Shape Memory Medical Inc. | Unresolved — no canonical attribution shown | $45.06 | 0.2% | 1 | 2025 |
| ARGON MEDICAL DEVICES, INC. | Unresolved — no canonical attribution shown | $43.40 | 0.2% | 1 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $36.51 | 0.1% | 1 | 2025 |
| Flowphysix Inc | Unresolved — no canonical attribution shown | $33.33 | 0.1% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $26.19 | 0.1% | 1 | 2025 |
| Teleflex LLC | Unresolved — no canonical attribution shown | $25.86 | 0.1% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $22.57 | 0.1% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $20.00 | 0.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $22,365.00 | 5 |
| Food and Beverage | $3,523.48 | 54 |
| Travel and Lodging | $1,143.04 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NANOKNIFE Normalized: nanoknife |
Device | AngioDynamics, Inc. | $11,539.15 | 10 | 2025 |
Source payment records
|
|||||
| Kronos Normalized: kronos |
Device | Single Pass Inc | $5,750.00 | 1 | 2025 |
Source payment records
|
|||||
| General - Therapies Normalized: general therapies |
Device | Boston Scientific Corporation | $4,500.00 | 2 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $231.98 | 3 | 2025 |
Source payment records
|
|||||
| HEPZATO KIT Normalized: hepzato kit |
Drug | Delcath Systems | $213.74 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $150.84 | 3 | 2025 |
Source payment records
|
|||||
| EMPRINT Normalized: emprint |
Device | Medtronic, Inc. | $148.09 | 2 | 2025 |
Source payment records
|
|||||
| Image Guided Therapy Agito Normalized: image guided therapy agito |
Device | Philips North America LLC | $133.62 | 1 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $132.85 | 2 | 2025 |
Source payment records
|
|||||
| Eye90 microspheres Normalized: eye90 microspheres |
Device | ABK Biomedical USA, Inc. | $123.47 | 2 | 2025 |
Source payment records
|
|||||
| MicroThermX Microwave Ablation System Normalized: microthermx microwave ablation system |
Device | Siemens Medical Solutions USA, Inc. | $119.63 | 1 | 2025 |
Source payment records
|
|||||
| Cryoablation needles Normalized: cryoablation needles |
Device | Boston Scientific Corporation | $98.75 | 1 | 2025 |
Source payment records
|
|||||
| SpyGlass Discover Normalized: spyglass discover |
Device | Boston Scientific Corporation | $89.18 | 4 | 2025 |
Source payment records
|
|||||
| ICEfx Cryoablation System Normalized: icefx cryoablation system |
Device | Boston Scientific Corporation | $80.56 | 2 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $70.67 | 2 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $62.81 | 3 | 2025 |
Source payment records
|
|||||
| COVERA Normalized: covera |
Device | Bard Peripheral Vascular, Inc. | $62.67 | 2 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $54.38 | 1 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $49.29 | 2 | 2025 |
Source payment records
|
|||||
| PALINDROME Normalized: palindrome |
Device | Mozarc Medical US LLC | $46.34 | 1 | 2025 |
Source payment records
|
|||||
| IMPEDE EMBOLIZATION PLUG Normalized: impede embolization plug |
Device | Shape Memory Medical Inc. | $45.06 | 1 | 2025 |
Source payment records
|
|||||
| Clot Management Normalized: clot management |
Device | ARGON MEDICAL DEVICES, INC. | $43.40 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $36.51 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $36.51 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $36.51 | 1 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $36.51 | 1 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $36.51 | 1 | 2025 |
Source payment records
|
|||||
| FLOWRUNNER Normalized: flowrunner |
Device | Flowphysix Inc | $33.33 | 1 | 2025 |
Source payment records
|
|||||
| TheraSphere360_PI Normalized: therasphere360 pi |
Device | Boston Scientific Corporation | $32.17 | 1 | 2025 |
Source payment records
|
|||||
| PowerPort ClearVUE isp Implantable Port Normalized: powerport clearvue isp implantable port |
Device | Becton, Dickinson and Company | $29.97 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $26.19 | 1 | 2025 |
Source payment records
|
|||||
| ARROW Normalized: arrow |
Device | Teleflex LLC | $25.86 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $22.57 | 1 | 2025 |
Source payment records
|
|||||
| Trek Normalized: trek |
Device | Becton, Dickinson and Company | $20.88 | 1 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $20.00 | 1 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $10.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $27,031.52 · 61 records | AngioDynamics, Inc. | ARROW, ARTIX MT, AZUR CX DETACHABLE, CGuard Prime Carotid Stent System, CLOTTRIEVER BOLD CATHETER, COVERA, Clot Management, Cryoablation needles, EMPRINT, ENDURANT IIS, ESPRIT, Eye90 microspheres, FLOWRUNNER, General - Therapies, HEPZATO KIT, ICEfx Cryoablation System, IMPEDE EMBOLIZATION PLUG, Image Guided Therapy Agito, Indigo System, Kronos, LIMFLOW SYSTEM, MicroThermX Microwave Ablation System, NANOKNIFE, PALINDROME, Penumbra System, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, PowerPort ClearVUE isp Implantable Port, SYMPHONY CATHETER, SpyGlass Discover, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, TheraSphere360_PI, Trek, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error